Osteoporosis Clinical Trials in Los Angeles

Showing 41-42 of 42 trials

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

NCT00046137

The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.

Osteoporosis, Postmenopausal

Eli Lilly and Company

Anaheim, California, United States • Oakland, California, United States • Altamonte Springs, Florida, United States +10 more locations

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Osteoporosis Trials in Other Cities

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Other Conditions in Los Angeles